Quantum Computing Stocks Rally on US Governments 2 Billion Funding Plan SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development Mango Heir Jonathan Andic Investigated in Connection with Fathers Death Citi Raises Price Target for Frontier Group Holdings After Fiscal First Quarter Results Paranova Expands Footprint with New St Neots Packaging Facility Amazon Stock Gains Favor Among Wall Street as Magnificent Seven Dynamics Shift MOLN Q4 2025 Earnings NarrowerThanExpected Loss Highlights Cost Control But Stock Edges Lower XERS Q1 2026 Earnings EPS Beat Driven by Strong Operational Execution Kewaunee Scientific Corporation KEQU Q1 2026 Earnings Reports 028 EPS Revenue Details Not Disclosed JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment Fiserv Inc FISV Holds Steady Near Support as Market Awaits Catalyst Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support PetMed Express PETS Slides 23 as Shares Test Key Support Levels PZG Shows Modest Uptick Testing Resistance Near 139 DXC Technology Holds Steady Above 9 as Modest Gains Emerge Enhanced Games Trump JrBacked Steroid Olympics Set to Debut in Las Vegas RPC Inc RES Q1 2026 Earnings EPS Surpasses Estimates Amid Disappointing Revenue Details and Stock Decline GPGI Inc GPGI Advances 145Holding Above Key Support as Resistance Nears Insperity Inc NSP Q1 2026 Earnings EPS Beat Drives Positive Market Response OXLCL Q4 2025 Earnings EPS Falls Short Amid Mixed Market Signals Carter Bankshares CARE Q1 2026 Earnings Massive EPS Miss Yet Stock Rises WHR Q1 2026 Earnings Deep EPS Miss Sends Shares Lower UL Solutions Q1 2026 Earnings EPS Surges Past Estimates with 20 Beat Sachem Capital Corp 600 Notes due 2027 SCCE Q4 2025 Earnings Massive EPS Surprise Highlights Resilient Operating Performance CMMB Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Biotech Continues Without Revenue